Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the launch of the aPAP ClearPath Dried Blood Spot (DBS) Test in the ...
The new findings are the first to describe distributions and perturbations of low-density granulocyte and normal-density ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback